Pharma/Biotech – USA, Europe, Asia and ROW Regulatory News – Oct 2024
USA
FDA Authorizes Neoadjuvant and Adjuvant Nivolumab for Respectable NSCLC
The FDA has approved Nivolumab (Opteva, Bristol Myers Squibb) in combination with platinum-based chemotherapy as a...
Biotech News, Cancer Treatment, Drug Approval, FDA Approval, Healthcare Updates, Medical Advancements, Medicines, Patient Care, Pharma News, Regulatory News